Elder Pharmaceuticals Ltd

Next 500 2015
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
#142(2015)
#142(2015)

Financial Data 2014

Revenue
1,296
(INR Cr)
Net Operating Income
1,009
(INR Cr)
Assets
1,642
(INR Cr)
Profit
-7
(INR Cr)
Net Worth
773
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS201420132012201120102009
Revenue
(INR Cr)
1296
-22.6%
1676
22.7%
1366
29.3%
1056
35.1%
782
20.0%
652
-
Net Operating Income
(INR Cr)
1009
-38.54%
1642
22.99%
1335
38.28%
965
33.77%
722
16.32%
620
12.54%
Profit
(INR Cr)
-7
-
82
14.0%
72
12.5%
64
29.7%
50
-18.6%
61
-
Assets
(INR Cr)
1642
-22.9%
2129
18.6%
1795
21.3%
1480
39.0%
1065
19.5%
891
-
Net Worth
(INR Cr)
773
0.5%
769
9.8%
701
11.1%
631
31.3%
480
22.5%
392
7.6%
Employee Cost
(INR Cr)
218
-6.5%
233
29.6%
180
51.1%
119
23.2%
97
15.3%
84
-
Interest Cost
(INR Cr)
276155102665341
Cash & Bank Balance
(INR Cr)
54710315426779146
Total Debt
(INR Cr)
84813441081832574499

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS201420132012201120102009
Profit As % Of Revenues -4.9%5.3%6.1%6.3%9.3%
Profit As % Of Assets -3.9%4.0%4.3%4.7%6.8%
Profit As % Of Networth -10.7%10.3%10.2%10.3%15.5%
Interest Cost to EBITDA % -57.2%50.7%39.5%44.9%42.4%
Debt to Equity Ratio 1.101.751.541.321.191.27
RONW -9.0%10.8%11.3%10.7%12.4%
ROCE -3.5%10.6%11.8%11.5%11.2%12.0%